Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NKG2D is an activating receptor expressed on NK cells, CD8+ T cells, and γδ T cells. It recognizes stress-induced ligands on target cells, triggering cytotoxicity and cytokine production. It plays a critical role in immunosurveillance against tumors, virally infected cells, and other stressed cells. NKG2D signaling is mediated through adaptor proteins DAP10 and DAP12. The receptor also regulates signaling through other receptors, both potentiating and inhibiting signals during different stages of the immune response.
Activation of effector functions (e.g., perforin/granzyme release) upon ligand binding, modulation of other receptor signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural Killer Group 2 Member D Receptor (NKG2D).